News

QHSLab, Inc. Meets the Demand for Updated Mental Health Screening Recommendations from the U.S. Preventive Services Task Force

The latest recommendations from the U.S. Preventive Services Task Force (USPSTF) indicate that all adults under the age of 65…

2 years ago

SciSparc: Wellution™ Signs an Agreement with Logistics Facilities in New Jersey to Supports its Expansion to Additional e-Commerce Platforms

Agreement is expected to optimize handling and shipment processes and reduce direct sales costs   TEL AVIV, Israel, Nov. 01, 2022…

2 years ago

Aileron Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights

Activated multiple existing and new sites under amended Phase 1b breast cancer clinical trial protocol; additional site activations anticipated in…

2 years ago

Dentsply Sirona Completes Internal Investigation

Announces Restatements of Third Quarter 2021 and Full Year 2021 Financials Reports Select Preliminary Third Quarter 2022 Results CHARLOTTE, N.C.,…

2 years ago

CymaBay Announces Appointment of Charles McWherter, Ph.D. to Chief Scientific Officer and President of Research and Development

NEWARK, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing…

2 years ago

Anika’s Cingal® Successfully Achieves Primary Endpoint in Third Phase III Study

Cingal 19-01: Significant Reduction in WOMAC Pain from Baseline 19-01: Change in WOMAC Pain from Baseline (ITT)Study Demonstrated Superiority of…

2 years ago

Phathom Pharmaceuticals Announces Placement of the Remaining $40 Million in Non-Dilutive Capital under its up to $300 Million Revenue Interest Financing Agreement

Up to $40 million committed, resulting in total financing of up to $300 million available to Phathom with total royalty…

2 years ago

Candel Therapeutics Upcoming Investor Conference Participation for November

NEEDHAM, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Nasdaq: CADL), a clinical stage biopharmaceutical company developing novel…

2 years ago

Paratek Pharmaceuticals to Present at the Credit Suisse 31st Annual Healthcare Conference

BOSTON, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development…

2 years ago

Galectin Therapeutics to Share Five Scientific Presentations at The Liver Meeting™ 2022, Hosted by the AASLD

Prevalence of esophageal and gastric varices in patients with compensated NASH cirrhosis and portal hypertensionBiochemical and imaging profiles in 271…

2 years ago